A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers

- Provide informed consent by signing the electronic Information and Consent Form.

- Male or females between the ages of 18 and 30 (inclusive) without regard to race or ethnic background

- Are in generally good health and have no medical conditions that would prevent or interfere with their participation in the study

- Are fully able and willing to comply with the requirements of the study

- Are fully able and willing to keep scheduled appointments

- Females that are pregnant, attempting to become pregnant or are currently lactating/nursing a child.

- Individuals currently taking prescription medications that are known to be immunosuppressants (e.g. dexamethasone, tacrolimus, methotrexate)

- Individuals with gastrointestinal conditions (e.g., inflammatory bowel disease, Crohn's disease, etc.) that may affect consumption of the treatment supplements.

- Individuals with clinically important renal, hepatic, cardiac pulmonary, pancreatic, neurologic or biliary disorders; insulin-dependent and orally controlled diabetics will also be excluded from the study.

- Individuals with a recent history of cancer other than non-melanoma skin cancer.

- Individual's that have trouble swallowing pills.

- Individuals that have participated as a subject in any other clinical study within 30 days of screening.

- Individuals with a history of alcohol abuse or other substance abuse within the previous 2 years.

- Individuals that currently use tobacco products including chewing tobacco and cigarettes.